ACS Medicinal Chemistry Letters · 2016 · 41 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsAntiparasitic AgentsAntiparasitic PharmacologyEnzyme InhibitionMalariaStructure-activity Relationship AnalysisAntimalarial AgentsAntimalarial Drug DevelopmentAntiparasitic Drug DiscoveryNovel Antiparasitic Compound ClassesPlasmodium FalciparumSelectivityTreatment Of Malaria
The identification of a new series of P. falciparum growth inhibitors is described. Starting from a series of known human class I HDAC inhibitors a SAR exploration based on growth inhibitory activity in parasite and human cells-based assays led to the identification of compounds with submicromolar inhibition of P. falciparum growth (EC50 < 500 nM) and good selectivity over the activity of human HDAC in cells (up to >50-fold). Inhibition of parasital HDACs as the mechanism of action of this new class of selective growth inhibitors is supported by hyperacetylation studies.
23
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Lúcio H. Freitas-Júnior, Rosaura Hernández‐Rivas, Stuart A. Ralph et al. · Cell · 2005 · 497 citations · Full text
The presence of acetyl groups in histones
DMP PHILLIPS · Biochemical Journal · 1963 · 492 citations · Full text